ATE120202T1 - Antiherpes-peptidderivate mit einem 1,4-dioxo-c4- n-terminus. - Google Patents
Antiherpes-peptidderivate mit einem 1,4-dioxo-c4- n-terminus.Info
- Publication number
- ATE120202T1 ATE120202T1 AT91109243T AT91109243T ATE120202T1 AT E120202 T1 ATE120202 T1 AT E120202T1 AT 91109243 T AT91109243 T AT 91109243T AT 91109243 T AT91109243 T AT 91109243T AT E120202 T1 ATE120202 T1 AT E120202T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- cycloalkyl
- hydrogen
- peptide derivatives
- dioxo
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000003602 anti-herpes Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- -1 1,2-cyclohexanediyl Chemical group 0.000 abstract 1
- 206010019973 Herpes virus infection Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000000464 thioxo group Chemical group S=* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002018801A CA2018801C (en) | 1990-06-12 | 1990-06-12 | Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus |
| US08/219,600 US5484771A (en) | 1990-06-12 | 1994-03-29 | Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE120202T1 true ATE120202T1 (de) | 1995-04-15 |
Family
ID=25674164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91109243T ATE120202T1 (de) | 1990-06-12 | 1991-06-06 | Antiherpes-peptidderivate mit einem 1,4-dioxo-c4- n-terminus. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5484771A (de) |
| EP (1) | EP0461546B1 (de) |
| JP (1) | JP3043833B2 (de) |
| AT (1) | ATE120202T1 (de) |
| CA (1) | CA2018801C (de) |
| DE (1) | DE69108299T2 (de) |
| IL (1) | IL98443A (de) |
| NZ (1) | NZ238455A (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE169931T1 (de) | 1992-03-12 | 1998-09-15 | Boehringer Ingelheim Ca Ltd | Isosterische peptidderivate gegen herpes |
| US5846941A (en) * | 1992-03-12 | 1998-12-08 | Boehringer Ingelheim (Canada) Ltd. | Isosteric antiherpes peptide derivatives II |
| US5830864A (en) * | 1992-03-12 | 1998-11-03 | Boehringer Ingelheim (Canada), Ltd. | Antiherpes peptide derivatives having a ureido n-terminus |
| WO2005026187A1 (ja) * | 2003-09-10 | 2005-03-24 | Riken | 非天然型塩基を有するヌクレオシド又はヌクレオチド及びその利用 |
| CA2927595C (en) * | 2004-12-22 | 2023-01-31 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| CA2625540C (en) | 2005-11-08 | 2017-03-21 | Ambrx, Inc. | Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides |
| US20080317670A1 (en) * | 2005-12-14 | 2008-12-25 | Ambrx, Inc. | Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| US9376438B2 (en) | 2011-05-17 | 2016-06-28 | Principia Biopharma, Inc. | Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors |
| US8962831B2 (en) | 2011-05-17 | 2015-02-24 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
| JP6203848B2 (ja) | 2012-09-10 | 2017-09-27 | プリンシピア バイオファーマ インコーポレイテッド | キナーゼ阻害剤としてのピラゾロピリミジン化合物 |
| US8957080B2 (en) | 2013-04-09 | 2015-02-17 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
| KR20160117614A (ko) | 2014-02-21 | 2016-10-10 | 프린시피아 바이오파마, 인코퍼레이티드 | Btk 억제제의 염 및 고체 형태 |
| AU2015364335B2 (en) | 2014-12-18 | 2020-11-26 | Principia Biopharma Inc. | Treatment of pemphigus |
| EP3313839A1 (de) | 2015-06-24 | 2018-05-02 | Principia Biopharma Inc. | Tyrosin-kinase-inhibitoren |
| KR102391693B1 (ko) | 2016-06-29 | 2022-04-29 | 프린시피아 바이오파마, 인코퍼레이티드 | 2-[3-[4-아미노-3-(2-플루오로-4-페녹시-페닐)피라졸로[3,4-d]피리미딘-1-일]피페리딘-1-카르보닐]-4-메틸-4-[4-(옥세탄-3-일)피페라진-1-일]펜트-2-엔니트릴의 변형 방출 제제 |
| CN121426803A (zh) | 2018-09-12 | 2026-01-30 | 诺华股份有限公司 | 抗病毒吡啶并吡嗪二酮化合物 |
| US11667613B2 (en) | 2019-09-26 | 2023-06-06 | Novartis Ag | Antiviral pyrazolopyridinone compounds |
| TWI877239B (zh) | 2019-10-14 | 2025-03-21 | 美商普林斯匹亞生物製藥公司 | 藉由投予(R)-2-[3-[4-胺基-3-(2-氟-4-苯氧基-苯基)吡唑并[3,4-d]嘧啶-1-基]哌啶-1-羰基]-4-甲基-4-[4-(氧呾-3-基)哌-1-基]戊-2-烯腈來治療免疫血小板減少症之方法 |
| MX2022009009A (es) | 2020-01-22 | 2022-08-15 | Principia Biopharma Inc | Formas cristalinas de 2-[3-[4-amino-3-(2-fluoro-4-fenoxi-fenil)-1h -pirazolo[3,4-d]pirimidin-1-il]piperidin-1-carbonil]-4-metil-4-[4 -(oxetan-3-il)piperazin-1-il]pent-2-enonitrilo. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341029C (en) * | 1985-02-04 | 2000-06-20 | Michael Kolb | Peptidase inhibitors |
| EP0292255A3 (de) * | 1987-05-22 | 1990-08-22 | Merck & Co. Inc. | Hemmungsstoff für Ribonukleotid-Reduktase |
| JPH04500963A (ja) * | 1988-09-26 | 1992-02-20 | ジ・アップジョン・カンパニー | マレアミド置換基を含有するレニン抑制ペプチド類 |
| DE3839559A1 (de) * | 1988-11-24 | 1990-05-31 | Hoechst Ag | Renin-hemmende aminodiol-derivate |
-
1990
- 1990-06-12 CA CA002018801A patent/CA2018801C/en not_active Expired - Fee Related
-
1991
- 1991-06-06 DE DE69108299T patent/DE69108299T2/de not_active Expired - Fee Related
- 1991-06-06 AT AT91109243T patent/ATE120202T1/de not_active IP Right Cessation
- 1991-06-06 EP EP91109243A patent/EP0461546B1/de not_active Expired - Lifetime
- 1991-06-10 NZ NZ238455A patent/NZ238455A/xx unknown
- 1991-06-11 JP JP03139081A patent/JP3043833B2/ja not_active Expired - Lifetime
- 1991-06-11 IL IL9844391A patent/IL98443A/en not_active IP Right Cessation
-
1994
- 1994-03-29 US US08/219,600 patent/US5484771A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3043833B2 (ja) | 2000-05-22 |
| EP0461546B1 (de) | 1995-03-22 |
| EP0461546A3 (en) | 1993-03-24 |
| DE69108299D1 (de) | 1995-04-27 |
| CA2018801A1 (en) | 1991-12-12 |
| NZ238455A (en) | 1993-12-23 |
| US5484771A (en) | 1996-01-16 |
| EP0461546A2 (de) | 1991-12-18 |
| IL98443A (en) | 1995-07-31 |
| DE69108299T2 (de) | 1995-08-10 |
| CA2018801C (en) | 2000-08-22 |
| JPH04243892A (ja) | 1992-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE120202T1 (de) | Antiherpes-peptidderivate mit einem 1,4-dioxo-c4- n-terminus. | |
| MD1743B2 (ro) | Derivaţi ai indolului, procedeu de obţinere a lor, compoziţie fungicidă şi procedeu de combatere a fungilor | |
| AU680704B2 (en) | Cyclic amide derivatives | |
| DK0590428T3 (da) | Azaquinoxaliner, fremgangsmåde til deres fremstilling og deres anvendelse | |
| MX9201577A (es) | Analogos de trifosfato de adenina. | |
| MY109069A (en) | Fungicidal derivatives of 2-alkoxy-2-imidazolin-5-ones | |
| ES8203078A1 (es) | Procedimiento para la obtencion de cianguanidina trisusti- tuidas, de efecto fungicida | |
| AU623500B2 (en) | Carboxylimino benzothiazole derivatives | |
| LV11037A (lv) | Herpes virusa ribonukleotidu reduktazes inhibitori | |
| KR950700322A (ko) | 이소스테릭 항헤르페스 펩타이드 유도체(Isosteric antiherpes peptide derivatives) | |
| DE69019786D1 (de) | Antiherpes-Tetrapeptid-Derivate mit einer substituierten Seitenkette aus Asparaginsäure. | |
| ZA919727B (en) | Process for the preparation of insecticidal,nematicidal and acaricidal 2-halo-3-substituted-5-arylpyrrole compounds | |
| NO304314B1 (no) | Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler | |
| AU5028893A (en) | N-aminoalkylcarbonyloxyalkylpyrrole insecticidal, acaricidal and molluscicidal agents | |
| AU660158B2 (en) | Improvements in stabilized isothiazolinone formulations | |
| AU5028093A (en) | N-substituted carbonyloxyalkylpyrrole insecticidal, acaricidal and molluscicidal agents | |
| AU640723B2 (en) | 2-formylbenzylphosphonic acid derivatives, their preparation and their use for the treatment of diseases caused by viruses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |